Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancer.
Title | Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancer. |
Publication Type | Journal Article |
Year of Publication | 2010 |
Authors | Chelis, L., Xenidis N., Amarantidis K., Prassopoulos P., Chamalidou E., Neanidis K., Mikroulis D., Chatzaki E., Karakitsos P., & Kakolyris S. |
Journal | Chemotherapy |
Volume | 56 |
Issue | 5 |
Pagination | 353-8 |
Date Published | 2010 |
ISSN | 1421-9794 |
Keywords | Aged, Antineoplastic Agents, Bridged-Ring Compounds, Carcinoma, Non-Small-Cell Lung, Cisplatin, Deoxycytidine, Drug Administration Schedule, Female, Humans, Kaplan-Meier Estimate, Lung Neoplasms, Male, Middle Aged, Taxoids, Vinblastine, Vinorelbine |
Abstract | BACKGROUND: To evaluate the activity and tolerance of gemcitabine (GEM) in combination with vinorelbine (VRL) in pretreated patients with advanced non-small cell lung cancer (NSCLC). |
DOI | 10.1159/000321549 |
Alternate Journal | Chemotherapy |
PubMed ID | 20926858 |